PT1024815E - Composicoes farmaceuticas para administracao oral de iodo molecular - Google Patents
Composicoes farmaceuticas para administracao oral de iodo molecularInfo
- Publication number
- PT1024815E PT1024815E PT98954002T PT98954002T PT1024815E PT 1024815 E PT1024815 E PT 1024815E PT 98954002 T PT98954002 T PT 98954002T PT 98954002 T PT98954002 T PT 98954002T PT 1024815 E PT1024815 E PT 1024815E
- Authority
- PT
- Portugal
- Prior art keywords
- iodine
- mammal
- molecular iodine
- molecular
- pharmaceutical compositions
- Prior art date
Links
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 title abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 5
- 229910052740 iodine Inorganic materials 0.000 abstract 5
- 239000011630 iodine Substances 0.000 abstract 5
- 241000124008 Mammalia Species 0.000 abstract 4
- 239000003638 chemical reducing agent Substances 0.000 abstract 2
- 210000004051 gastric juice Anatomy 0.000 abstract 2
- 238000001727 in vivo Methods 0.000 abstract 2
- 239000007800 oxidant agent Substances 0.000 abstract 2
- 230000001590 oxidative effect Effects 0.000 abstract 2
- 238000006479 redox reaction Methods 0.000 abstract 2
- 210000002784 stomach Anatomy 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/960,149 US5885592A (en) | 1997-10-29 | 1997-10-29 | Methods and pharmaceutical compositions for oral delivery of molecular iodine |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1024815E true PT1024815E (pt) | 2003-06-30 |
Family
ID=25502851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT98954002T PT1024815E (pt) | 1997-10-29 | 1998-10-27 | Composicoes farmaceuticas para administracao oral de iodo molecular |
Country Status (17)
Country | Link |
---|---|
US (1) | US5885592A (pt) |
EP (1) | EP1024815B1 (pt) |
JP (1) | JP4187410B2 (pt) |
KR (1) | KR100412219B1 (pt) |
CN (1) | CN1150904C (pt) |
AT (1) | ATE231725T1 (pt) |
AU (1) | AU750627B2 (pt) |
BR (1) | BR9812588A (pt) |
CA (1) | CA2301503C (pt) |
DE (1) | DE69811105T2 (pt) |
DK (1) | DK1024815T3 (pt) |
ES (1) | ES2191973T3 (pt) |
IL (1) | IL134778A0 (pt) |
NO (1) | NO20001673L (pt) |
PT (1) | PT1024815E (pt) |
RU (1) | RU2213564C2 (pt) |
WO (1) | WO1999021567A1 (pt) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6248335B1 (en) * | 1997-10-29 | 2001-06-19 | Symbollon Corporation | Stabilized oral pharmaceutical composition containing iodide and iodate and method |
WO1999034809A1 (fr) * | 1998-01-06 | 1999-07-15 | Fujisawa Pharmaceutical Co., Ltd. | Preparations solides a base d'iodophore et procede de fabrication correspondant |
DE69910210T2 (de) | 1998-06-19 | 2004-06-17 | Oxibio, Inc., Portland | Implantierbare medizinische vorrichtung mit antiinfektiösen und kontrazeptiven eigenschaften |
US6154672A (en) * | 1998-06-22 | 2000-11-28 | Pacesetter, Inc. | Method and apparatus for improving the probability of success of defibrillation shocks |
GB2395901A (en) * | 1999-02-26 | 2004-06-09 | Symbollon Corp | Stabilised tablets containing iodide and iodate |
PT1195178E (pt) * | 2000-10-06 | 2006-10-31 | Dmg Italia Srl | Preparacao imunotrofica para o tratamento da hipertrofia adenoamigdalar. |
ES2359818T3 (es) * | 2003-06-20 | 2011-05-27 | Hill's Pet Nutrition, Inc. | Métodos para hipertiroidismo en un gato y composición que comprende yodo limitado. |
US8501223B2 (en) * | 2003-06-20 | 2013-08-06 | Hill's Pet Nutrition, Inc. | Methods for dietary management of cats to avoid hyperthyroidism |
CA2823751C (en) * | 2006-01-26 | 2015-10-06 | Hill's Pet Nutrition, Inc. | Methods and compositions for treating feline hyperthyroidism |
CA2650845C (en) * | 2006-05-12 | 2015-07-07 | Hill's Pet Nutrition, Inc. | Compositions and methods for preventing or treating chronic renal failure in felines with hyperthyroidism |
US8303994B2 (en) * | 2006-06-22 | 2012-11-06 | Jack Howard Kessler | Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells |
CA2656608C (en) * | 2006-07-03 | 2014-09-16 | Hill's Pet Nutrition, Inc. | Compositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism |
US8226964B2 (en) * | 2006-09-07 | 2012-07-24 | Biolargo Life Technologies, Inc. | Systems and methods for cleaning liquid carriers related applications data |
US7943158B2 (en) * | 2006-09-07 | 2011-05-17 | BioLargo Life Technologies, Inc | Absorbent systems providing antimicrobial activity |
US8021610B2 (en) * | 2006-09-07 | 2011-09-20 | Biolargo Life Technologies, Inc. | Systems providing antimicrobial activity to an environment |
US7867510B2 (en) * | 2006-09-07 | 2011-01-11 | BioLargo Life Technologies, Inc | Material having antimicrobial activity when wet |
US9414601B2 (en) * | 2006-09-07 | 2016-08-16 | Biolargo Life Technologies, Incorporated | Material having antimicrobial activity when wet |
US20080063560A1 (en) * | 2006-09-07 | 2008-03-13 | Biolargo Life Technologies, Incorporated | Ground treatment for reducing microbial content |
US8257749B2 (en) * | 2007-02-08 | 2012-09-04 | Biolargo Life Technologies, Incorporated | Systems providing at least pesticidal activity |
WO2009087647A1 (en) * | 2008-01-07 | 2009-07-16 | Council Of Scientific & Industrial Research | A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders |
MX340005B (es) * | 2010-04-23 | 2016-05-18 | Univ Nac Autónoma De México | Composicion de yodo molecular de uso humano para la prevencion y tratamiento de patologias prostaticas. |
EP2606885B1 (en) * | 2011-05-16 | 2016-05-11 | Begaliev, Shokan Sabirkhanovich | Medicinal preparation "renessans" having an antibacterial, anti-ulcerous and immuno-modulating action |
CN102697804B (zh) * | 2012-06-07 | 2014-02-12 | 维尔信科技(潍坊)有限公司 | 一种固态分子碘消毒制剂及其制备方法 |
US10034899B2 (en) * | 2013-11-27 | 2018-07-31 | BioPharmX, Inc. | Solid oral dosage form for breast symptoms |
JP6573620B2 (ja) * | 2014-02-10 | 2019-09-11 | フレッド ハッチンソン キャンサー リサーチ センター | 心臓発作及び虚血損傷のハロゲン治療 |
WO2015153258A1 (en) | 2014-03-31 | 2015-10-08 | Iotech International, Llc | Stable compositions of uncomplexed iodine and methods of use |
EA031907B1 (ru) * | 2016-03-11 | 2019-03-29 | Тимур Хусаинович Измайлов | Шашка иодная дымовая |
WO2017185060A1 (en) | 2016-04-21 | 2017-10-26 | BioPharmX, Inc. | Oral iodine dosage form |
KR20190123716A (ko) | 2016-07-21 | 2019-11-01 | 아이오젠, 엘엘씨 | 연화성 국소 소독제 |
CN106727683A (zh) * | 2016-12-23 | 2017-05-31 | 刘海涛 | 一种药物制剂在制备治疗幽门螺杆菌感染性疾病的药物中的应用 |
TW202203900A (zh) * | 2020-03-31 | 2022-02-01 | 越南商泰明製藥股份有限公司 | 用於治療癌症、子宮內膜異位症以及癌症或子宮內膜異位症患者的疼痛之二異丙胺化合物以及碘 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2540170C3 (de) * | 1975-09-10 | 1979-01-18 | Basf Ag, 6700 Ludwigshafen | Verwendung von in organischer Lösung hergestelltem Polyvinylpyrrolidon zur Herstellung von stabilen wäßrigen PoIyvinylpyrrolidon-Jod-Lösungen |
US4259322A (en) * | 1978-03-20 | 1981-03-31 | Helong Lim | Method of treatment of tuberculosis |
US4187294A (en) * | 1978-07-06 | 1980-02-05 | Nihon Nousan Kougyou Co., Ltd. | Method for producing eggs containing a high amount of iodinated amino acids |
JPS5663919A (en) * | 1979-10-29 | 1981-05-30 | Nippon Nousan Kogyo Kk | Remedial composition for diabetes |
JPS57140723A (en) * | 1981-02-25 | 1982-08-31 | Nippon Nousan Kogyo Kk | Preventing composition for hyperlipemia due to neutral fat |
US5171582A (en) * | 1985-07-31 | 1992-12-15 | Ghent William R | Treatment of iodine deficiency diseases |
US5250304A (en) * | 1985-07-31 | 1993-10-05 | Ghent William R | Treatment of iodine deficiency diseases |
US5589198A (en) * | 1985-07-31 | 1996-12-31 | 943038 Ontario, Inc. | Treatment of iodine deficiency diseases |
US4816255A (en) * | 1985-07-31 | 1989-03-28 | Ghent William R | Treatment of iodine deficiency breast syndrome |
US5629024A (en) * | 1994-08-22 | 1997-05-13 | Symbollon Corporation | Method of forming an iodine based germicide composition |
-
1997
- 1997-10-29 US US08/960,149 patent/US5885592A/en not_active Expired - Lifetime
-
1998
- 1998-10-21 IL IL13477898A patent/IL134778A0/xx not_active IP Right Cessation
- 1998-10-27 WO PCT/US1998/022720 patent/WO1999021567A1/en active IP Right Grant
- 1998-10-27 ES ES98954002T patent/ES2191973T3/es not_active Expired - Lifetime
- 1998-10-27 DE DE69811105T patent/DE69811105T2/de not_active Expired - Lifetime
- 1998-10-27 KR KR10-2000-7003542A patent/KR100412219B1/ko not_active IP Right Cessation
- 1998-10-27 EP EP98954002A patent/EP1024815B1/en not_active Expired - Lifetime
- 1998-10-27 RU RU2000107852/14A patent/RU2213564C2/ru not_active IP Right Cessation
- 1998-10-27 JP JP2000517725A patent/JP4187410B2/ja not_active Expired - Fee Related
- 1998-10-27 AU AU11227/99A patent/AU750627B2/en not_active Ceased
- 1998-10-27 AT AT98954002T patent/ATE231725T1/de not_active IP Right Cessation
- 1998-10-27 PT PT98954002T patent/PT1024815E/pt unknown
- 1998-10-27 BR BR9812588-5A patent/BR9812588A/pt not_active Application Discontinuation
- 1998-10-27 CA CA002301503A patent/CA2301503C/en not_active Expired - Fee Related
- 1998-10-27 DK DK98954002T patent/DK1024815T3/da active
- 1998-10-27 CN CNB988097648A patent/CN1150904C/zh not_active Expired - Fee Related
-
2000
- 2000-03-31 NO NO20001673A patent/NO20001673L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2213564C2 (ru) | 2003-10-10 |
ATE231725T1 (de) | 2003-02-15 |
BR9812588A (pt) | 2000-07-25 |
WO1999021567A1 (en) | 1999-05-06 |
IL134778A0 (en) | 2001-04-30 |
CN1272789A (zh) | 2000-11-08 |
US5885592A (en) | 1999-03-23 |
CA2301503A1 (en) | 1999-05-06 |
ES2191973T3 (es) | 2003-09-16 |
JP4187410B2 (ja) | 2008-11-26 |
EP1024815B1 (en) | 2003-01-29 |
DE69811105D1 (de) | 2003-03-06 |
AU750627B2 (en) | 2002-07-25 |
DE69811105T2 (de) | 2003-11-06 |
CA2301503C (en) | 2005-01-04 |
NO20001673D0 (no) | 2000-03-31 |
NO20001673L (no) | 2000-05-24 |
AU1122799A (en) | 1999-05-17 |
CN1150904C (zh) | 2004-05-26 |
JP2003510243A (ja) | 2003-03-18 |
EP1024815A1 (en) | 2000-08-09 |
KR20010030861A (ko) | 2001-04-16 |
DK1024815T3 (da) | 2003-05-19 |
KR100412219B1 (ko) | 2003-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1024815E (pt) | Composicoes farmaceuticas para administracao oral de iodo molecular | |
EP0699072A4 (en) | IRON-BINDING POLYMERS FOR ORAL ADMINISTRATION | |
HK1077501A1 (en) | Improved delivery of multiple doses of a methylphenidate drug | |
NZ262679A (en) | Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell | |
MXPA02010322A (es) | Metodos para la prevencion y tratamiento de trastornos gastrointestinales. | |
GR1002097B (en) | A process for providing a composition an analgesic in combination with a h1 or h2 receptor blocker proto n pump ihibitor or combination thereof | |
ATE394107T1 (de) | Vorbeugung und behandlung von kolonadenom oder kolonmikroadenom mit 6-fluorursodeoxycholsäure | |
SI0770384T1 (en) | Solid, anhydrous, pharmaceutical compositions for vaginal use | |
EP1007055A4 (en) | METHODS OF ADMINISTERING AMIFOSTINE | |
CA2032475A1 (en) | Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines | |
EP1064950A4 (en) | NEW REMEDIES AGAINST HEPATITIS | |
EP0805684A4 (en) | METHODS OF IMPROVING THE THERAPEUTIC ACTIVITY OF NON-STEROID ANTI-INFLAMMATORY DRUGS (NSAIDS) AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREFOR | |
EP1073436A4 (en) | IMPROVED METHOD FOR ERADICATION OF HELICOBACTER PYLORI | |
AU1656997A (en) | Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer | |
EP0271151A3 (en) | Azumolene dosage form | |
EP0835662A3 (en) | A drug for the treatment of cancer | |
SE8701077D0 (sv) | Pharmaceutical composition | |
CA2234936A1 (en) | Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine | |
WO1998057626A1 (en) | Use of l-arginine or a pharmaceutically acceptable salt thereof for production of drugs for treatment of helicobacter pylori infections | |
DK1019066T3 (da) | Fremgangsmåder og præparater til forebyggelse og behandling af halsbrand | |
ATE240097T1 (de) | Pharmaceutische zusammensetzung enthaltend (+)- ephedrin und einen h1 rezeptor antagonisten | |
OSBORNE | The treatment of Helicobacter pylori infection in the management of peptic ulcer disease | |
RU97110400A (ru) | Способ профилактики и лечения больных, страдающих эстрогенно- и андрогенозависимыми опухолями | |
RU94013463A (ru) | Способ и композиция для лечения заболеваний желудка и двенадцатиперстной кишки и новые производные пге2 | |
UA10335A (uk) | Спосіб корекції порушеhь обміhу кальцію у хворих hа сиhдром рейтера хламідійhої етіології |